4DMedical logo

4DMedical(ASX) 4DX

Market CapA$2.29BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2020)+139%
5 Year+207%
1 Year+122%
1 Month+9%
A$4.08
+7.37%
+0.28Today
4DMedical last closing stock price
MetricPriceDate
Last closeAUD 4.082026-10-15
4DMedical stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+3.29%AUD 3.952026-10-08
1 month+9.09%AUD 3.742026-09-15
3 month+27.5%AUD 3.202026-07-17
Year to date+3.82%AUD 3.932025-12-31
1 year+121.74%AUD 1.842025-10-15
3 year+750%AUD 0.482023-10-16
5 year+206.77%AUD 1.332021-10-15
Since inception+138.99%AUD 1.592020-08-07

4DMedical Financials at a Glance

Market Cap

A$2.29BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$11.44M

Net Income (TTM)

-A$229.05M

EPS (TTM)

-A$0.40

P/E Ratio

-9.62

Dividend

A$0.00

Beta (Volatility)

0.11 (Low)

Price

A$4.08

Volume

4,128,090

Open

A$3.84

Previous Close

A$4.08

Daily Range

A$3.68 - A$4.10

52-Week Range

A$1.40 - A$7.55

Estimated Earnings Date

Feb 26, 2027

4DX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About 4DMedical

4DMedical Limited is a medical technology company based in Carlton, Australia, specializing in advanced lung imaging solutions. The firm focuses on its proprietary XV Technology, which offers four-dimensional lung imaging, enhancing diagnostic capabilities in respiratory health.

Products and Services
  • Innovative XV Technology for four-dimensional lung imaging
  • Software-as-a-service (SaaS) delivery model for lung ventilation analysis
  • Permetium, a preclinical imaging system for pulmonary function assessment
Growth Outlook
  • Recent quarterly revenue increased to AUD 4.21 million, showing growth potential
  • Strong cash position with AUD 277.95 million in cash and equivalents
  • Market demand for advanced imaging technologies is expected to rise
Financial Highlights
  • Trailing twelve months (TTM) revenue of AUD 12.5 million reflects growth
  • Current ratio of 30.79 indicates strong liquidity
  • Net income for the latest quarter was a loss of AUD 50.30 million
4DMedical Limited operates in a promising sector, leveraging innovative technology to address critical healthcare needs. The company's focus on advanced imaging solutions positions it well for future growth, especially as the demand for enhanced diagnostic tools continues to rise. Despite recent financial losses, the substantial cash reserves provide a buffer for ongoing research and development, enabling the company to pursue its strategic objectives. Investors may find the potential for long-term growth appealing, particularly in light of the increasing emphasis on respiratory health and advanced medical technologies.
AI Generated • Sep 20, 2026

Industry

Health Care Technology

Sector

Health Care

Employees

181

CEO

Andreas Fouras, PhD

Website

www.4dmedical.com

Headquarters

Carlton, VIC 3053, AU

4DX Financials

Key Financial Metrics (TTM)

Gross Margin

-539.23%

Operating Margin

-813.68%

Net Income Margin

-2895.06%

Return on Equity

-288.42%

Return on Capital

-33.14%

Return on Assets

-55.96%

Earnings Yield

-10.40%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$2.29BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

602.03M

Volume

4.13M

Avg. Volume

4.44M

Financials (TTM)

Gross Profit

-A$34.03M

Operating Income

-A$94.31M

EBITDA

-A$82.51M

Operating Cash Flow

-A$55.59M

Capital Expenditure

-A$1.01M

Free Cash Flow

-A$56.60M

Cash & ST Invst.

A$277.95M

Total Debt

A$3.22M

4DMedical Performance Analysis

4DMedical annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30AUD 718,581-31.8%
20242024-06-30AUD 3,754,256422.5%
20252025-06-30AUD 5,853,40155.9%
20262026-06-30AUD 7,061,54620.6%
4DMedical sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-31-2.2%
Q42025-06-30-48.9%
Q22025-12-3192.8%
Q42026-06-3047.6%
4DMedical annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30AUD -0.1025.6%
20242024-06-30AUD -0.10-7.4%
20252025-06-30AUD -0.07-27.0%
20262026-06-30AUD -0.38437.4%
4DMedical sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-3137.5%
Q42025-06-3057.1%
Q22025-12-31-2230.8%
Q42026-06-3072.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

A$4.21M

+42.1%

Gross Profit

-A$19.56M

-804.7%

Gross Margin

-4.65%

N/A

Market Cap

A$2.29BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$12.64M

N/A

Employees

181

N/A

Net Income

-A$50.30M

-146.9%

EBITDA

-A$28.22M

-42.5%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

A$277.95M

+808.2%

Total Debt

A$3.22M

-37.2%

Accounts Receivable

A$9.46M

+650.6%

Inventory

A$216.83K

-78.1%

Long Term Debt

A$2.19M

-47.5%

Short Term Debt

A$1.03M

+8.5%

Return on Assets

-55.96%

N/A

Return on Invested Capital

-16.14%

N/A

Free Cash Flow

-A$19.43M

-20.0%

Operating Cash Flow

-A$18.61M

-15.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
OIL.AXOptiscan Imaging Limited
A$0.14-9.68%
M7T.AXMach7 Technologies Limited
A$0.23+2.27%
SHG.AXSingular Health Group Ltd
A$0.16-11.11%
IME.AXImExHS Limited
A$0.31-7.58%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$42.52+13.63%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$110.54-13.35%
TQQQProShares Trust - ProShares UltraPro Qqq
$74.12-5.95%
NOKNokia
$9.40-4.67%

Questions About 4DX

What is the current price of 4DMedical?

4DMedical is trading at A$4.08 per share.

What is the 52-week range for 4DMedical?

Over the past 52 weeks, 4DMedical has traded between A$1.40 and A$7.55.

How much debt does 4DMedical have?

As of the most recent reporting period, 4DMedical reported total debt of A$11.17M.

How much cash does 4DMedical have on hand?

4DMedical reported A$277.95M in cash and cash equivalents in its most recent financial results.

What is 4DMedical’s dividend yield?

4DMedical does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services